NCT01532739 · ACTIVE NOT RECRUITING

Making Memory Better for Seniors With Mild Cognitive Impairment

This trial tests a group-based cognitive training program for people with Mild Cognitive Impairment (MCI). It focuses on everyday memory problems and pairs traditional memory exercises with a structured problem-solving approach. Phase NA here means this is a feasibility and effectiveness study — essentially asking whether the program works in a real-world clinical setting, not a standard drug trial with phased approval stages.

You may qualify if

  • Clinical diagnosis of Mild Cognitive Impairment

You're excluded if

  • Clinical diagnosis of dementia
  • History of neurological conditions known to impair cognition
  • History of alcohol or drug abuse
  • History of chronic psychiatric illness
  • Current symptoms of moderate to severe depression (Geriatric Depression Scale >19) or anxiety (Beck Anxiety Inventory >15)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-08-21

View full record on ClinicalTrials.gov

All APOE4 clinical trials